ID
35500
Description
Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 3/6/19 3/6/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 6, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)
Medical Procedures
- StudyEvent: ODM
Description
Medical Procedures
Alias
- UMLS CUI-1
- C0199171
Description
If ‘Yes’, please record details below using standard medical terminology (Please print clearly)
Data type
boolean
Alias
- UMLS CUI [1]
- C0199171
Description
Medical procedure
Data type
text
Alias
- UMLS CUI [1]
- C0199171
Description
Medical procedure, Indication
Data type
text
Alias
- UMLS CUI [1,1]
- C0199171
- UMLS CUI [1,2]
- C3146298
Description
Medical procedure, Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0199171
- UMLS CUI [1,2]
- C0808070
Description
Medical procedure, End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0199171
- UMLS CUI [1,2]
- C0806020
Similar models
Medical Procedures
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])